Sleep therapy adherence under the microscope: do obese patients keep using their machines?

NCT ID NCT07363070

Completed Knowledge-focused Sponsor: Anne Kathrine Staehr-Rye Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how consistently 300 obese adults (BMI over 30) used positive airway pressure therapy for sleep-disordered breathing. Researchers tracked whether patients used the device at least 4 hours per night for 70% of nights within the first 90 days and again after one year. The goal was to describe real-world adherence patterns, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Positive airway pressure therapy (a device that helps keep airways open during sleep)
What this could lead to: If successful, this could help doctors understand why some patients stop using their sleep therapy, leading to better support and improved health outcomes.
What could go wrong: This is an observational study, not a treatment trial, so it won't test new therapies. Results may not apply to all sleep apnea patients, only those referred to a specific clinic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHERENCE, TREATMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder sleep apnea syndrome sleep-wake disorder Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHERENCE, TREATMENT OBESITY SLEEP DISORDER; BREATHING-RELATED

Contacts and locations

Locations

Respiratory Center East, Rigshospitalet

Glostrup Municipality, 2600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.